Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsZenith Epigenetics Ltd. announced the initiation of a Phase IIb TNBC clinical trial combining ZEN-3694 + Pfizer Inc.’s Talzenna.
[Zenith Epigenetics Ltd.]
Home Newsletters Mammary Cell News Zenith Epigenetics Announces Initiation of a Phase IIb Triple Negative Breast Cancer...
